Search

everythinglearnresearchcommunity

for

Search:↓

High TNF-α levels may increase hair loss risk after PRP therapy.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Balding scalps show different gene expressions affecting hair growth compared to non-balding scalps.

The research found new potential mechanisms in mouse hair growth by studying RNA interactions.

The TRPV3 gene mutation affects hair growth by keeping mice in the growth phase longer, which could help treat hair loss.

Brassica oleracea extract, glucosinlates, and sulforaphane can boost hair growth and might be used to treat hair loss.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

Adding Triamcinolone to the anesthetic can reduce swelling after hair transplants, and using Platelet-Rich Plasma can improve hair thickness and patient satisfaction. The SRD5A2 gene also plays a key role in the success of hair transplants.

The research provided new insights into the genetic factors contributing to hair loss and skin conditions by analyzing individual cells from the human scalp.

TMPRSS2 is crucial for COVID-19 infection and is a potential target for treatment.

DNA analysis can help tailor alopecia treatment.

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

CEC levels may be a useful marker for predicting prostate cancer progression.

New treatments for hair growth and psoriasis may be possible, and gene differences could affect baldness and the severity of skin conditions.

The study found that androgen receptors in skin cells mainly affect the focal adhesion pathway and control the caveolin-1 gene, with implications for new treatments for related diseases.

Organ transplant recipients have a higher risk of skin cancer over time, atopic dermatitis skin shows unusual bacterial and fungal patterns, a new tool for measuring hidradenitis suppurativa severity was created, and gene expression changes in male baldness suggest new treatments.

Targeting specific genes in certain pathways may help treat male pattern baldness.

Certain gene changes and hormone levels are linked to female hair loss.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

Balding hair follicles have less growth-promoting factors and more inhibitory factors, leading to hair loss.

EDA2R is a key gene linked to ageing and diseases, and targeting it may help treat conditions like hair loss and chronic diseases.

Knocking out the FGF5 gene in sheep increased wool production and hair-follicle density.

CAG repeat numbers in the AR gene likely don't affect male pattern baldness in Korean men.

TGFβ-2 may cause hair loss in androgenetic alopecia.

Immune changes and specific genes contribute to male hair loss.

A substance called prostaglandin D2 is found more in bald scalps and it stops hair from growing. Blocking its receptor could potentially treat hair loss.

Androgens help motor neurons grow by increasing neuritin.

Androgenetic alopecia is mainly caused by genetic factors and increased androgen activity, leading to hair follicle miniaturization.